These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 16931226)

  • 41. Parathyromatosis: critical diagnosis regarding surgery and pathologic evaluation.
    Aksoy-Altinboga A; Akder Sari A; Rezanko T; Haciyanli M; Orgen Calli A
    Korean J Pathol; 2012 Apr; 46(2):197-200. PubMed ID: 23110001
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Severe hyperparathyroidism despite paricalcitol therapy: one-year follow-up.
    Shuja SB; Raja RM
    Adv Perit Dial; 2003; 19():231-5. PubMed ID: 14763069
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Parathyromatosis type 2 detected by
    Cao H; Zeng M; Fang H; Tang L; Liu W
    Gland Surg; 2019 Dec; 8(6):806-809. PubMed ID: 32042690
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Treatment of secondary hyperparathyroidism in CKD patients with cinacalcet and/or vitamin D derivatives.
    Drüeke TB; Ritz E
    Clin J Am Soc Nephrol; 2009 Jan; 4(1):234-41. PubMed ID: 19056615
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Medical-surgical integrated approach in the treatment of non-paraneoplasic hyperparathyroidism: our experience].
    Pulvirenti D; Aikaterini T; Campagna A; Ignaccolo L; Giustolisi N; Costa E
    Clin Ter; 2008; 159(5):307-10. PubMed ID: 18998031
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Persistent elevated serum levels of intact parathyroid hormone after reoperation for primary hyperparathyroidism and after pamidronate therapy.
    Darcan S; Coker M; Aydinok Y; Gökşen D; Ozok G
    Turk J Pediatr; 2003; 45(3):269-72. PubMed ID: 14696811
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Denosumab for the treatment of bisphosphonate resistant hypercalcemia in a hemodialysis patient.
    Dahmani O; Sophoclis C; Kebir M; Bouguern D; Sakho A; Demarchi P
    Saudi J Kidney Dis Transpl; 2017; 28(1):154-157. PubMed ID: 28098117
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Risk of parathyromatosis after fine-needle aspiration.
    Kendrick ML; Charboneau JW; Curlee KJ; van Heerden JA; Farley DR
    Am Surg; 2001 Mar; 67(3):290-3; discussion 293-4. PubMed ID: 11270891
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cinacalcet for secondary hyperparathyroidism in patients receiving hemodialysis.
    Block GA; Martin KJ; de Francisco AL; Turner SA; Avram MM; Suranyi MG; Hercz G; Cunningham J; Abu-Alfa AK; Messa P; Coyne DW; Locatelli F; Cohen RM; Evenepoel P; Moe SM; Fournier A; Braun J; McCary LC; Zani VJ; Olson KA; Drüeke TB; Goodman WG
    N Engl J Med; 2004 Apr; 350(15):1516-25. PubMed ID: 15071126
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Surgical approach in the treatment of recurrent primary hyperparathyroidism].
    Lumachi F; Favia G; D'Amico DF
    Ann Ital Chir; 1993; 64(4):371-3. PubMed ID: 8154659
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Parathyroidectomy versus cinacalcet hydrochloride-based medical therapy in the management of hyperparathyroidism in ESRD: a cost utility analysis.
    Narayan R; Perkins RM; Berbano EP; Yuan CM; Neff RT; Sawyers ES; Yeo FE; Vidal-Trecan GM; Abbott KC
    Am J Kidney Dis; 2007 Jun; 49(6):801-13. PubMed ID: 17533023
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Clinical profile and outcome of primary hyperparathyroidism accompanied by chronic renal failure.
    Mizumoto D; Watanabe Y; Fukuzawa Y; Aoi N; Yamazaki C
    Clin Nephrol; 1994 Nov; 42(5):315-21. PubMed ID: 7851033
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The calcimimetic cinacalcet normalizes serum calcium in renal transplant patients with persistent hyperparathyroidism.
    Kruse AE; Eisenberger U; Frey FJ; Mohaupt MG
    Nephrol Dial Transplant; 2005 Jul; 20(7):1311-4. PubMed ID: 15941846
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Preoperative localization of parathyroid tissue with technetium-99m sestamibi 123I subtraction scanning.
    Thulé P; Thakore K; Vansant J; McGarity W; Weber C; Phillips LS
    J Clin Endocrinol Metab; 1994 Jan; 78(1):77-82. PubMed ID: 8288719
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Relapsing secondary hyperparathyroidism due to multiple nodular formations after total parathyroidectomy with autograft.
    Falvo L; Catania A; Sorrenti S; D'Andrea V; Santulli M; De Antoni E
    Am Surg; 2003 Nov; 69(11):998-1002. PubMed ID: 14627264
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cinacalcet treatment in dialysis patients with secondary hyperparathyroidism: effects and open issues.
    Drüeke TB
    Ther Apher Dial; 2008 Oct; 12 Suppl 1():S2-12. PubMed ID: 19032522
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Primary hyperparathyroidism mimicking vaso-occlusive crises in sickle cell disease.
    Krishnamoorthy P; Alyaarubi S; Abish S; Gale M; Albuquerque P; Jabado N
    Pediatrics; 2006 Aug; 118(2):e537-9. PubMed ID: 16882790
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Basic and clinical aspects of calcimimetics. Calcimimetic is indicated for patients with surgically uncontrollable hyperparathyroidism].
    Tominaga Y
    Clin Calcium; 2008 Jan; 18(1):67-71. PubMed ID: 18175874
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Sonographic localisation procedures in hyperparathyroidism -- persistent hyperparathyroidism after removal of four parathyroid glands].
    Rewerk S; Post S; Willeke F
    Ultraschall Med; 2005 Apr; 26(2):146-9. PubMed ID: 15852179
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Tertiary hyperparathyroidism: histologic patterns of disease and results of parathyroidectomy.
    Kebebew E; Duh QY; Clark OH
    Arch Surg; 2004 Sep; 139(9):974-7. PubMed ID: 15381615
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.